Research has shown that there are decreased levels of C3 and C4 proteins and higher levels of complement activation products such as C3a, C5a, and soluble C5b-9 (sC5b-9) in the synovial fluid of RA patients (45, 46). This evidence concerns the gene C4A and rheumatoid arthritis.